IDH1 and glioblastoma: Comparable data in IDH-wildtype glioblastoma remain limited, as most patients succumb to disease before hypermutation-driven recurrence can be fully characterized, though the phenomenon has been documented in recurrent IDH-wildtype glioblastoma [24].